These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 25545036
1. Emerging treatments in Neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist. Camilleri M, Acosta A. Neurogastroenterol Motil; 2015 Mar; 27(3):324-32. PubMed ID: 25545036 [Abstract] [Full Text] [Related]
2. Relamorelin for the treatment of gastrointestinal motility disorders. Chedid V, Camilleri M. Expert Opin Investig Drugs; 2017 Oct; 26(10):1189-1197. PubMed ID: 28847163 [Abstract] [Full Text] [Related]
3. Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis. Lembo A, Camilleri M, McCallum R, Sastre R, Breton C, Spence S, White J, Currie M, Gottesdiener K, Stoner E, RM-131-004 Trial Group. Gastroenterology; 2016 Jul; 151(1):87-96.e6. PubMed ID: 27055601 [Abstract] [Full Text] [Related]
4. Relamorelin Relieves Constipation and Accelerates Colonic Transit in a Phase 2, Placebo-Controlled, Randomized Trial. Acosta A, Camilleri M, Kolar G, Iturrino J, Szarka LA, Boldingh A, Burton D, Ryks M, Rhoten D, Zinsmeister AR, Spence SC, Gottesdiener K, Bouras EP, Vazquez-Roque MI. Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2312-9.e1. PubMed ID: 26001337 [Abstract] [Full Text] [Related]
5. Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study. Camilleri M, McCallum RW, Tack J, Spence SC, Gottesdiener K, Fiedorek FT. Gastroenterology; 2017 Nov; 153(5):1240-1250.e2. PubMed ID: 28760384 [Abstract] [Full Text] [Related]
6. Therapeutic applications of ghrelin agonists in the treatment of gastroparesis. Shin A, Wo JM. Curr Gastroenterol Rep; 2015 Feb; 17(2):430. PubMed ID: 25702264 [Abstract] [Full Text] [Related]
13. Ghrelin as a target for gastrointestinal motility disorders. Greenwood-Van Meerveld B, Kriegsman M, Nelson R. Peptides; 2011 Nov; 32(11):2352-6. PubMed ID: 21453735 [Abstract] [Full Text] [Related]
14. Effects of ghrelin receptor agonist, relamorelin, on gastric motor functions and satiation in healthy volunteers. Nelson AD, Camilleri M, Acosta A, Busciglio I, Linker Nord S, Boldingh A, Rhoten D, Ryks M, Burton D. Neurogastroenterol Motil; 2016 Nov; 28(11):1705-1713. PubMed ID: 27283792 [Abstract] [Full Text] [Related]
17. Gastric motor effects of ghrelin and growth hormone releasing peptide 6 in diabetic mice with gastroparesis. Qiu WC, Wang ZG, Wang WG, Yan J, Zheng Q. World J Gastroenterol; 2008 Mar 07; 14(9):1419-24. PubMed ID: 18322959 [Abstract] [Full Text] [Related]
18. Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists. Mosińska P, Zatorski H, Storr M, Fichna J. J Neurogastroenterol Motil; 2017 Apr 30; 23(2):171-179. PubMed ID: 28238253 [Abstract] [Full Text] [Related]